Contributor Disclosures for Liver Transplantation, Complications

Role Name Disclosure Details Author  Paul D Russ, MD, Professor, Department of Radiology, Sections of Abdominal Imaging and Ultrasound, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Rondle M Moubry II, MD, Assistant Professor, Assistant Chief, Denver Veterans Administration Medical Center, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Douglas E Elliott, MD, Staff Physician, Department of Radiology, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Janette D Durham, MD, Associate Professor, Department of Radiology, Division of Interventional Radiology, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Kavita Garg, MD, Professor, Department of Radiology, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Michael E Wachs, MD, Associate Professor of Surgery, Division of Transplant Surgery, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Igal Kam, MD, Professor of Surgery, Director of Liver Transplant Program and Head, Division of Transplant Surgery, Department of Surgery, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Thomas E Bak, MD, Assistant Professor of Surgery, Division of Transplant Surgery, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Gregory T Everson, MD, FACP, Professor of Medicine, Director, Section of Hepatology, Division of Gastroenterology, University of Colorado Health Sciences Center Roche Roche Pharmassett Schering-Plough Vertex Source GSK GlobeImmune Ortho Biotech Details Coauthor  James F Trotter, MD, Associate Professor, Department of Medicine, Division of Gastroenterology and Hepatology, Medical Director of Liver Transplantation, University of Colorado Health Sciences Center Nothing to disclose Details Coauthor  Thomas Trouillot, MD, Colorado Gastroenterology Nothing to disclose Details Coauthor  Marcelo Kugelmas, MD, Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center Nothing to disclose Details Medical Editor  Neela Lamki, MD, Professor, Department of Radiology, Sultan Qaboos University, Oman; Adjunct Professor, Department of Radiology, Baylor College of Medicine Nothing to disclose Details Pharmacy Editor  Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand Nothing to disclose Details Managing Editor  Udo P Schmiedl, MD, PhD, Clinical Professor, Department of Radiology, University of Washington; Consulting Staff, Swedish Medical Center, University of Washington Medical Center, Seattle Radiologists Nothing to disclose Details CME Editor  Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute Nothing to disclose Details Chief Editor  John Karani, MBBS, FRCR, Consulting Staff, Department of Radiology, King's College Hospital, London Nothing to disclose Details CONTRIBUTOR DISCLOSURE FORM Contributor Name: Paul D Russ  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication None. Contributor Disclosure Contributor: Contributor Disclosure: Rondle M Moubry, II, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Douglas E Elliott, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Janette D Durham, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Kavita Garg  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Michael E Wachs, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Igal Kam  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Thomas E Bak, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Gregory Thomas Everson  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Roche Grant/research funds Research   Roche Honoraria Speaking and teaching   Pharmassett Grant/research funds Research   Schering-Plough Grant/research funds Research   Vertex Grant/research funds Research   Source Grant/research funds Research   GSK Grant/research funds Research   GlobeImmune Grant/research funds Research   Ortho Biotech Grant/research funds Research   Off label or investigational use of medication Peginterferon and ribavirin in treatment of patients prior to and after liver transplantation. Contributor Disclosure Contributor: Contributor Disclosure: James Trotter, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Thomas Trouillot, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Marcelo Kugelmas, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Neela Lamki  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Bernard D Coombs, Pharmacy Editor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Udo P Schmiedl, Managing Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Robert M Krasny  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: John Karani  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication